Australia markets closed

Journey Medical Corporation (DERM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.9000+0.1000 (+2.63%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-4,159
-3,853
-29,628
-43,994
5,283
-
Depreciation & amortisation
3,600
3,855
4,365
2,560
1,516
-
Deferred income taxes
-
-
0
1,566
-335
69
Stock-based compensation
3,366
2,606
4,425
2,466
153
-
Change in working capital
-5,744
-1,655
6,187
14,709
-2,232
-
Accounts receivable
17,502
12,551
-5,380
768
-5,022
-
Inventory
2,698
3,953
1,744
-8,458
-547
-
Accounts payable
-28,315
-18,421
14,343
20,388
-152
-
Other working capital
1,177
240
-33,534
-12,181
3,932
-
Other non-cash items
656
709
833
20,017
698
-
Net cash provided by operating activities
1,177
5,240
-13,534
-2,181
5,132
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-5,000
-20,000
-10,000
-1,200
-
Other investing activities
-
-
-20,000
-
-
-
Net cash used for investing activities
0
-5,000
-20,000
-10,000
-1,200
-
Cash flows from financing activities
Debt repayment
-24,000
-51,948
-7,864
-11,488
-500
-
Common stock issued
5,978
4,494
0
32,536
0
-
Other financing activities
-
-471
-585
-3,546
-
-
Net cash used provided by (used for) financing activities
-3,219
-4,804
16,456
53,016
-487
-
Net change in cash
-2,042
-4,564
-17,078
40,835
3,445
-
Cash at beginning of period
26,099
32,003
49,081
8,246
4,801
-
Cash at end of period
24,057
27,439
32,003
49,081
8,246
-
Free cash flow
Operating cash flow
1,177
5,240
-13,534
-2,181
5,132
-
Capital expenditure
-
-5,000
-20,000
-10,000
-1,200
-
Free cash flow
1,177
240
-33,534
-12,181
3,932
-